Retinitis Pigmentosa (RP) Active Not Recruiting Phase 2 Trials for Cenegermin (DB13926)

Also known as: Retinitis Pigmentosa / Pigmentary maculopathy / Albipunctate retinal dystrophy

IndicationStatusPhase
DBCOND0056216 (Retinitis Pigmentosa (RP))Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02609165Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular EdemaTreatment